Advertisement
Screener

Aurinia Pharmaceuticals Inc. (AUPH) ROE

Aurinia Pharmaceuticals Inc. (AUPH) ROE

  • 2026-06-30: ROE 51.09%.
  • 2026-03-31: ROE 52.54%.
  • 2025-12-31: ROE 49.40%.
  • 2025-09-30: ROE 21.28%.

Complete source-backed roe history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3051.09%
2026-03-3152.54%
2025-12-3149.40%
2025-09-3021.28%
2025-06-3018.08%
2025-03-3111.38%
2024-12-311.52%
2024-09-30-5.81%
2024-06-30-13.81%
2024-03-31-17.40%
2023-12-31-20.64%
2023-09-30-19.70%
2023-06-30-18.54%
2023-03-31-24.78%
2022-12-31-26.68%
2022-09-30-27.27%
2022-06-30-36.98%
2022-03-31-37.54%
2021-12-31-37.77%
2021-09-30-52.22%
2021-06-30-44.42%
2021-03-31-34.34%
2020-12-31-25.18%

Annual ROE

DateROE
2025-12-3149.40%
2024-12-311.52%
2023-12-31-20.64%
2022-12-31-26.68%
2021-12-31-37.77%
2020-12-31-25.18%
2019-12-31-29.60%
2018-12-31-39.11%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zai Lab Ltd (ZLAB)$2.241B-113.34
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Generate Biomedicines, Inc. (GENB)United States$2.052B